comparemela.com

Latest Breaking News On - Colin kellaher - Page 7 : comparemela.com

Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences

By Colin Kellaher Regeneron Pharmaceuticals has inked a deal with privately held Mammoth Biosciences to research, develop and commercialize Crispr-based gene-editing therapies targeting .

Bristol Myers Shedding 2,200 Jobs in Cost Savings Push

By Colin Kellaher Bristol Myers Squibb on Thursday said it plans to cut more than 2,000 jobs as part of an initiative aimed at generating about $1.5 billion in cost savings by the end of next.

ImmunityBio Shares Soar Premarket on FDA Nod for Anktiva

By Colin Kellaher Shares of ImmunityBio jumped more than 25% in premarket trading Tuesday after the immunotherapy company received Food and Drug Administration approval of its Anktiva.

Nordson Names Daniel Hopgood Chief Financial Officer

By Colin Kellaher Nordson has hired Eaton executive Daniel Hopgood to succeed Joseph Kelley as the precision technology company s top finance executive. Nordson on Tuesday said Hopgood,.

Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics

By Colin Kellaher Vertex Pharmaceuticals has struck an exclusive licensing agreement with privately held TreeFrog Therapeutics in a bid to bolster production of its cell therapies for type-1.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.